| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B
|
Xie, Zhe
|
|
|
229 |
C |
p.
|
article
|
| 2 |
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19
|
Oliveira, Ernna H.
|
|
|
229 |
C |
p.
|
article
|
| 3 |
Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant
|
Ji, Jia
|
|
|
229 |
C |
p.
|
article
|
| 4 |
Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease
|
Westover, Jonna B.
|
|
|
229 |
C |
p.
|
article
|
| 5 |
Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection
|
Xu, Yongru
|
|
|
229 |
C |
p.
|
article
|
| 6 |
Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in Japan
|
Chon, Irina
|
|
|
229 |
C |
p.
|
article
|
| 7 |
Direct-acting antivirals for RSV treatment, a review
|
Bonneux, Brecht
|
|
|
229 |
C |
p.
|
article
|
| 8 |
β-d-N 4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus
|
Konishi, Kei
|
|
|
229 |
C |
p.
|
article
|
| 9 |
Editorial Board
|
|
|
|
229 |
C |
p.
|
article
|
| 10 |
Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors
|
Andreev, Konstantin
|
|
|
229 |
C |
p.
|
article
|
| 11 |
High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro
|
Chen, Dongdong
|
|
|
229 |
C |
p.
|
article
|
| 12 |
Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial
|
Yotsuyanagi, Hiroshi
|
|
|
229 |
C |
p.
|
article
|
| 13 |
The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate
|
Wensel, David
|
|
|
229 |
C |
p.
|
article
|
Journal description